Sunday

4th Dec 2022

Thousands march in India against EU trade deal

  • Opponents of the deal say an EU request for a 'data exclusivity' clause will drive up the price of generic drugs made in India (Photo: e-Magine Art)

Thousands of HIV-positive protesters took to the streets in downtown New Delhi on Wednesday (2 March), concerned that an imminent EU-India free trade agreement (FTA) will end the production of affordable life-prolonging drugs.

The rally of more than 2,000 demonstrators from India and other Asian countries coincided with the re-start of sensitive trade negotiations in Brussels, with officials suggesting an end to the 2007-initiated talks is in sight.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

But opponents of the deal say an EU request for a 'data exclusivity' clause will drive the price of generic drugs made in India above an affordable level for people in poorer countries.

"More than 80 percent of the AIDS drugs our medical practitioners use to treat 175,000 people in developing countries are affordable generics from India," said Paul Cawthorne, a spokesman for Paris-based humanitarian group Medecins Sans Frontieres (MSF).

"Beyond AIDS, we rely on producers in India for drugs to treat other illnesses, such as tuberculosis and malaria. We cannot afford to let our patients lifeline be cut," Mr Cawthorne added, reports AFP.

Medicines have proved a sticking point in the ongoing discussions, with the EU keen to secure India's commitment to a strong intellectual property rights regime with respect to drugs.

European drug manufacturers complain that many of their patented products are frequently undercut by generics produced in India. EU customs officials have seized a number of containments bound for the 27-member state market over the past few years.

Until recently, Indian regulations allowed pharmaceutical companies to patent only drug-making processes and not the final products. Pressure from the World Trade Organisation has resulted in a tightening of those rules, but not as much as the EU would like.

Critics of the FTA say Europe's demand for 'data exclusivity' would mean that clinical trial data filed by one company could not be relied upon by other companies. As a result, the need for each firm to produce its own clinical trial tests would dramatically increase the price of medicines, they complain.

The United Nations is among those who also fear 'data exclusivity' provisions could act like a patent and block more affordable generic medicines from the market.

"It would be a colossal mistake to introduce data exclusivity in India, when millions of people across the globe depend on the country as the pharmacy of the developing world'," said Anand Grover, the UN Special Rapporteur on the Right to Health.

The EU is India's largest trading partner. Bilateral trade in goods and services between the two sides in 2009 was worth just under €69 billion, according to European Commission figures.

Another sensitive issue in the talks relates to the automobile sector, one of the subjects being discussed by commission and Indian negotiators this week. Here Europe is pushing for a reduction in Indian import tariffs on European cars, currently around 110 percent. Indian car manufacturers are against the move.

"We are aware of the position of the Indian car industry with respect to the negotiations," EU trade spokesman John Clancy told the Business Standard newspaper this week. "But it is clear that in order for the EU to support this agreement, access to India's car market must be improved significantly."

A compromise deal could revolve around the abolition of tariffs on high-end, luxury cars, while small models retain a degree of protection.

Opinion

Why are our medicines so expensive?

The EU should be promoting open innovation in upcoming trade talks with India and should work to bring down the prices of essential medicines, both abroad and within its borders.

Opinion

EU must break Orbán's veto on a tax rate for multinationals

This global tax rate for multinationals could yield up to €64bn annually. Yet, the Hungarian government led by Viktor Orbán has been blocking it for months. The impotency of the EU to strike a deal is irresponsible and incomprehensible.

Turkey's EU-funded detention centres ripe with abuse: NGO

Afghan and Syrian nationals are being abused at EU-funded removal centres in Turkey amid a lack of proper monitoring, says Human Rights Watch. The findings come at a time when Turkey is deporting large numbers of Afghans back to Kabul.

Portugal was poised to scrap 'Golden Visas' - why didn't it?

Over the last 10 years, Portugal has given 1,470 golden visas to people originating from countries whose tax-transparency practices the EU finds problematic. But unlike common practice in other EU states with similar programmes, Portugal has not implemented "due diligence".

Stakeholders' Highlights

  1. Nordic Council of MinistersCOP27: Food systems transformation for climate action
  2. Nordic Council of MinistersThe Nordic Region and the African Union urge the COP27 to talk about gender equality
  3. International Sustainable Finance CentreJoin CEE Sustainable Finance Summit, 15 – 19 May 2023, high-level event for finance & business
  4. Friedrich Naumann Foundation European DialogueGender x Geopolitics: Shaping an Inclusive Foreign Security Policy for Europe
  5. Obama FoundationThe Obama Foundation Opens Applications for its Leaders Program in Europe
  6. EFBWW – EFBH – FETBBA lot more needs to be done to better protect construction workers from asbestos

Latest News

  1. EU must break Orbán's veto on a tax rate for multinationals
  2. Belarus dictator's family loves EU luxuries, flight data shows
  3. How Berlin and Paris sold-out the EU corporate due diligence law
  4. Turkey's EU-funded detention centres ripe with abuse: NGO
  5. In green subsidy race, EU should not imitate US
  6. EU Commission proposes suspending billions to Hungary
  7. EU: Russian assets to be returned in case of peace treaty
  8. Frontex leadership candidates grilled by MEPs

Stakeholders' Highlights

  1. European Committee of the RegionsRe-Watch EURegions Week 2022
  2. UNESDA - Soft Drinks EuropeCall for EU action – SMEs in the beverage industry call for fairer access to recycled material
  3. Nordic Council of MinistersNordic prime ministers: “We will deepen co-operation on defence”
  4. EFBWW – EFBH – FETBBConstruction workers can check wages and working conditions in 36 countries
  5. Nordic Council of MinistersNordic and Canadian ministers join forces to combat harmful content online
  6. European Centre for Press and Media FreedomEuropean Anti-SLAPP Conference 2022

Join EUobserver

Support quality EU news

Join us